期刊
JOURNAL OF CYSTIC FIBROSIS
卷 9, 期 3, 页码 212-216出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcf.2010.02.004
关键词
Urinary biomarkers; Urinary creatinine; Cystic fibrosis; Normalization factor; Specific gravity; Pulmonary exacerbation
资金
- Cystic Fibrosis Foundation (CFF) [LAGUNAO6A0]
- National Institutes of Health (NIH) [1UO1HL081335-01, UL1 RR025780, M01 RR00069]
Background: Urine specimens are commonly used in biomarker research. Urinary creatinine (UCr) is often used to adjust for urine analyte concentration. We aim to explore the applicability of UCr as a normalization method in a cystic fibrosis (CF) population during hospitalization. Methods: Multiple spot urine samples were collected from CF patients hospitalized for a pulmonary exacerbation. Single spot specimens were obtained from asthmatics and healthy children for comparison. The assumptions and implications from the use of UCr as a normalization factor for urinary desmosine measurements were investigated. Results: UCr differed significantly across disease groups and decreased significantly over time in the CF population. Differing results were obtained when contrasting normalization by UCr with specific gravity. Conclusions: UCr levels are not completely attributable to simply variations in urine concentration. Analysis of urinary biomarker measurements should be initiated with an understanding of the relative effects of the normalization process on the results. (C) 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据